Rutherford Colin 4
4 · Evofem Biosciences, Inc. · Filed May 9, 2018
Insider Transaction Report
Form 4
Rutherford Colin
Director
Transactions
- Award
Stock option (right to buy)
2018-05-08+12,875→ 12,875 totalExercise: $6.99Exp: 2028-05-08→ Common Stock (12,875 underlying)
Footnotes (1)
- [F1]The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of May 8, 2018. The option was awarded in connection with Mr. Rutherford's board and committee services.